Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression
B. Balicka-Slusarczyk, P. Kopinski, J. Chorostowska-Wynimko, K. Sladek, G. Pinis, J. Soja, J. Garlicki, K. Szablowska, A. Szpechcinski, J. Szczeklik (Krakow, Bydgoszcz, Warszawa, Poland)
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Balicka-Slusarczyk, P. Kopinski, J. Chorostowska-Wynimko, K. Sladek, G. Pinis, J. Soja, J. Garlicki, K. Szablowska, A. Szpechcinski, J. Szczeklik (Krakow, Bydgoszcz, Warszawa, Poland). Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression. Eur Respir J 2008; 32: Suppl. 52, 1871
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Low apoptosis rate as a reason of local immune cell accumulation in interstitial lung diseases (ILD). The role of cytokine network Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006
Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Broncholaveolar lavage (BAL) lymphocytes from patients with interstitial lung diseases (ILD) produce hepatocyte growth factor (HGF) Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009
Does tumor necrosis factor-α (TNFα) protect immune cells from apoptosis in lower airways? Source: Eur Respir J 2007; 30: Suppl. 51, 111s Year: 2007
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001
The death receptors (DRs) expressed on alveolar lymphocytes (AL) in interstitial lung diseases (ILD) participate in apoptosis regulation Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012
Transcriptomic profiling of alveolar type 2 cells from mice expressing an ILD associated SFTPCI73T mutation supports their role in inflammatory cell recruitment and fibrotic lung remodeling. Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018
The influence of sera from interstitial lung diseases (ILD) patients on human mononuclear cells (MNC) production of vascular endothelial growth factor (VEGF) Source: Eur Respir J 2004; 24: Suppl. 48, 553s Year: 2004
IL-18, a novel Th1 cytokine, is up-regulated in pulmonary tuberculosis: expression and production by alveolar epithelial cells type II Source: Eur Respir J 2002; 20: Suppl. 38, 213s Year: 2002
Overexpression of B cell activating factor (BAFF) in peripheral lung of COPD patients Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009
Expression of insulin-growth factor-I (IGF-I) in alveolar lymphocytes (AL) in interstitial lung diseases (ILD). Potential functions of AL-derived IGF Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Enhanced expression of interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial (AE) cells Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013
Does tumour necrosis factor-alpha (TNF-alpha) induced by lipopolysaccharide have a positive feedback effect on the up-regulation of interleukin-8 (IL-8) messenger RNA by monocytes from COPD patients? Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013
High dimensional single cell analysis reveals unexpected immune cell types, and loss of motility and chemokine receptor expression of alveolar macrophages in chronic obstructive respiratory disease Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018
Upregulation of the production of TGF-β and IL-4 and downregulation of IL-6 by apoptotic human bronchial epithelial cells: possible role in regulation of epithelial repair following acute lung injury Source: Eur Respir J 2001; 18: Suppl. 33, 477s Year: 2001
Elevated integrin ?5 expression in idiopathic pulmonary fibrosis (IPF) derived fibroblasts is linked to paracrine TNF-a signaling Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017
Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008